| Name | Title | Contact Details |
|---|
ZERO - The End of Prostate Cancer is a 501 non-profit organization dedicated to prostate cancer education, testing, patient support, research and advocacy.
Professional Dynamics is a Folsom, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Amino, the leading healthcare guidance platform, connects people with high-quality, cost-effective providers and benefits programs in context across the healthcare ecosystem. With more than 17B healthcare claims used to inform our actionable healthcare recommendations, Amino reduces wasteful claims spending, streamlines care routing, increases care quality, and improves member experience.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
San Gabriel Valley Mosquito and Vector Control District monitors and controls vectors and the diseases they can spread. Our services and programs protect public health from mosquito-borne diseases.